R3 Bio pitches ethically charged brainless human clones
mit technology review released an ebook on r3 bio, a startup pitching 'brainless human clones' as backup bodies. the book explores the firm's ethically charged vision for immortality via stem-cell therapies.
MIT Technology Review published a subscriber-only eBook detailing the operations of R3 Bio. The startup is developing 'brainless human clones' intended to serve as vessels for human consciousness, pitching this as a solution for extending human life. The report highlights the significant ethical concerns surrounding the use of stem-cell therapies to create synthetic bodies without cognitive function.